[go: up one dir, main page]

AT349155B - Verfahren zur herstellung eines antiserums zur quantitativen bestimmung von hochmolekularen abbauprodukten des fibrins und fibrinogens - Google Patents

Verfahren zur herstellung eines antiserums zur quantitativen bestimmung von hochmolekularen abbauprodukten des fibrins und fibrinogens

Info

Publication number
AT349155B
AT349155B AT488376A AT488376A AT349155B AT 349155 B AT349155 B AT 349155B AT 488376 A AT488376 A AT 488376A AT 488376 A AT488376 A AT 488376A AT 349155 B AT349155 B AT 349155B
Authority
AT
Austria
Prior art keywords
fibrinogens
antisera
fibrin
preparation
high molecular
Prior art date
Application number
AT488376A
Other languages
English (en)
Other versions
ATA488376A (de
Inventor
Wolfgang Dr Stephan
Ronald Dr Kotitschke
Original Assignee
Biotest Serum Institut Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut Gmbh filed Critical Biotest Serum Institut Gmbh
Publication of ATA488376A publication Critical patent/ATA488376A/de
Application granted granted Critical
Publication of AT349155B publication Critical patent/AT349155B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT488376A 1975-07-18 1976-07-05 Verfahren zur herstellung eines antiserums zur quantitativen bestimmung von hochmolekularen abbauprodukten des fibrins und fibrinogens AT349155B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2532151A DE2532151C3 (de) 1975-07-18 1975-07-18 Antisenim zur quantitativen Bestimmung der Abbauprodukte des Fibrins und Fibrinogen« und Verfahren zu seiner Herstellung

Publications (2)

Publication Number Publication Date
ATA488376A ATA488376A (de) 1978-08-15
AT349155B true AT349155B (de) 1979-03-26

Family

ID=5951831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT488376A AT349155B (de) 1975-07-18 1976-07-05 Verfahren zur herstellung eines antiserums zur quantitativen bestimmung von hochmolekularen abbauprodukten des fibrins und fibrinogens

Country Status (9)

Country Link
US (1) US4147765A (de)
JP (1) JPS5212922A (de)
AT (1) AT349155B (de)
CH (1) CH620299A5 (de)
DE (1) DE2532151C3 (de)
FR (1) FR2318423A1 (de)
GB (1) GB1527268A (de)
NL (1) NL7607289A (de)
SE (1) SE7608174L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59192285U (ja) * 1983-06-08 1984-12-20 栗原　信雄 表示灯付きコ−ド接続具
JPS59192922U (ja) * 1983-06-09 1984-12-21 横浜ゴム株式会社 空気式防「げん」材
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
FR2565984B1 (fr) * 1984-06-19 1986-08-29 Rhone Poulenc Sante Nouvelles substances biologiquement actives, leur procede de preparation a partir du fibrinogene bovin et les compositions qui les contiennent
US5116613A (en) * 1985-01-08 1992-05-26 The General Hospital Corporation Antibody-thrombolytic agent product and method of use
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
WO1988001514A1 (en) * 1986-08-25 1988-03-10 American Biogenetic Sciences, Inc. Monoclonal antibodies to fibrin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5453359A (en) 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
AU741338B2 (en) * 1996-09-20 2001-11-29 Bristol-Myers Squibb Company Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1362776A (en) * 1970-07-17 1974-08-07 Wellcome Found Immunological reagent

Also Published As

Publication number Publication date
JPS5654586B2 (de) 1981-12-26
GB1527268A (en) 1978-10-04
FR2318423A1 (fr) 1977-02-11
US4147765A (en) 1979-04-03
DE2532151B2 (de) 1977-05-12
JPS5212922A (en) 1977-01-31
DE2532151A1 (de) 1977-01-20
SE7608174L (sv) 1977-01-19
DE2532151C3 (de) 1979-06-13
ATA488376A (de) 1978-08-15
CH620299A5 (de) 1980-11-14
FR2318423B1 (de) 1981-08-07
NL7607289A (nl) 1977-01-20

Similar Documents

Publication Publication Date Title
AT341056B (de) Verfahren zur herstellung von filmen und uberzugen und mittel zur durchfuhrung des verfahrens
ATA559275A (de) Verfahren zur herstellung von stickstoff- haltigen kondensationsprodukten
AT348253B (de) Verfahren zur polymerisation von aethylen und/oder alfa-olefinen
AT349155B (de) Verfahren zur herstellung eines antiserums zur quantitativen bestimmung von hochmolekularen abbauprodukten des fibrins und fibrinogens
AT336891B (de) Verfahren zur herstellung von wasserunloslichen hydrophilen copolymeren
ATA599875A (de) Verfahren zur herstellung von athylen-butadien-copolymeren
AT343893B (de) Verfahren zur herstellung von homo- und copolymerisaten
AT344496B (de) Verfahren zur verhinderung von aeroben abbauvorgaengen im gaerfutter und mittel zur durchfuehrung des verfahrens
ATA359375A (de) Verfahren zur herstellung von alfa-6-desoxy-5-hydroxytetracyclin und dessen hydrochlorids
DD128562A5 (de) Verfahren zur herstellung von 7-methoxy-cephalosporinen und deren salzen
ATA387076A (de) Verfahren zur herstellung von homo- und copolymerisaten des tetrafluorathylens
AT329181B (de) Verfahren zur herstellung von neuen 7-acylamido-3-fluor-3-cephem-4-carbonsaureestern und -sauren
DD134871A5 (de) Verfahren zur herstellung von pyrrolochinoxalinonen und pyrrolobenzdiazepinonen
DD130575A5 (de) Verfahren zur herstellung von neuen aethern und antibiotika
ATA44576A (de) Verfahren zur herstellung von n- (alfa-alkoxyathyl)-carbonsaureamiden
AT341078B (de) Verfahren zur gleichzeitigen gewinnung von insulin und pankreatin
DD129554A5 (de) Verfahren zur herstellung von iminothiazolidinonderivaten und diese enthaltende mittel
AT354092B (de) Verfahren zur herstellung beschichteter holz- werkstoffe und schichtstoffe
AT339280B (de) Verfahren zur herstellung von phloroglucin
AT317861B (de) Verfahren zur Herstellung von 2,3-Dichlor-1-acetoxypropan und 1,3-Dichlor-2-acetoxypropan
DE2316050A1 (de) Verfahren zur herstellung von 2-hydroxyaethylimino-diacetonitril und 2-hydroxyaethylimino-diacetaten
AT341686B (de) Verfahren zur herstellung von vincamon und vincanol
ATA851675A (de) Verfahren zur herstellung von 1-phenyl-2-glycinamidoathanolen- (1) und von deren salzen
AT350790B (de) Verfahren zur herstellung von homo- und misch- polymerisaten des aethylens
DD126302A5 (de) Verfahren zur herstellung von triazolen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee